The tariff war between US and China has eased, but with the Iran conflict and an erratic Trump, uncertainty will continue into 2027. Energy prices have gone ballistic, with gas prices doubling in Europe and has hit the cyclical stocks hard. The highly anticipated AI productivity gains also will have to transpire sooner or later or a US market correction becomes unavoidable. While the macro-economic impact has been limited so far, a prolonged uncertain situation will result in economic damage. We...
Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority) PARIS, March 04, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting rights02/28/2026100,590,994105,825,561 For further information on Cellectis, please contact: Media contacts: Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93 Inve...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 04 mars 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 DateNombre total d’actions composant le capital socialNombre total de droits de vote28/02/2026100 590 994105 825 561 Pour de plus amples informations sur Cellectis, veuillez contacter : Contacts média : Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, Patricia Sosa Navar...
Aedifica and Cofinimmo: Aedifica acquires c.80% of the shares in Cofinimmo. ASM International: 4Q25 results; strong FY26 guidance. D'Ieteren: Bloomberg reports on Belron IPO, valuation above $30bn, close to $40bn. dsm-firmenich: Symrise 2025 results and guidance. Kinepolis: Feb reassures - US box office revenue up +1% YoY, France visitors up +25% YoY. KPN: Odido data breach
Aedifica NV/SA – Results for the Initial Acceptance Period of Aedifica’s Exchange Offer for all Cofinimmo shares More information is available on Aedifica’s website via the link below and can be accessed subject to the usual restrictions.
Disclosure of trading in own shares on March 2, 2026 Head Office : 4 allée de l'Arche, 92400 Courbevoie, FranceTel : + 33 (0) 1 78 15 00 00 – a French Société Anonyme with a share capital of € 43,744,779 – R.C.S. Nanterre 393 525 852 – Id VAT FR 74 393 525 852 Disclosure of trading in own shares March 2, 2026 Issuer : Nexans Category : treasury shares Pursuant to applicable law on share buybacks, Nexans declares the following purchases of its own shares on March 2, 2026 The trades have been executed within the framewo...
Déclaration hebdomadaire des transactions sur actions propres le 2 mars 2026 Siège Social : 4 allée de l'Arche, 92400 Courbevoie, FranceTél : + 33 (0) 1 78 15 00 00 – S.A. au capital de 43 744 779 euros – R.C.S. Nanterre 393 525 852 – Id TVA FR 74 393 525 852 Déclaration des transactions sur actions propres Période : 2 mars 2026 Emetteur : Nexans Catégorie : Actions propres Conformément à la réglementation relative aux rachats d'actions, Nexans déclare ci-après les transactions sur actions propres réalisées le 2 mars 2026 ...
Fagron completes acquisition of Vepakum Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 3 March 2026 – 7:00AM Fagron completes acquisition of Vepakum Fagron, the leading global player in pharmaceutical compounding, announces the successful completion of its acquisition of Vepakum in Latin America. The transaction, announced in December 2025, was finalized following regulatory clearance from CADE in early February 2026. Vepakum operates two facilities in São Paulo, Brazil, and specializes in high-quality pharmaceutical packaging solutions. The ac...
Fagron voltooit overname van Vepakum Gereglementeerde informatie - voorwetenschapNazareth (België)/Rotterdam (Nederland), 3 maart 2026 – 7:00 Fagron voltooit overname van Vepakum Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, maakt bekend dat de overname van Vepakum in Latijns-Amerika succesvol is afgerond. De transactie, die in december 2025 werd aangekondigd, kon worden voltooid nadat CADE, de Braziliaanse mededingingsautoriteit, in februari 2026 goedkeuring verleende. Vepakum beschikt over twee productiefaciliteiten in São Paulo, Brazilië, en is gespecial...
Information on share capital and voting rights - February 2026 Information on share capital and voting rights February 2026 Statement made in accordance with article L. 233-8 II of the French commercial Code and articles 221-1 2 ° f) and 223-16 of the AMF Regulations. March 2nd, 2026 Statement made by: Nexans S.A.Registered office : 4 Allée de l’Arche - 92400 CourbevoieRCS Nanterre 393 525 852Regulated market of Euronext Paris (Compartment A) Date Total number of shares Total number of voting rightsTheorical (1)Exercisable (2)February 27th, 202643,744,77943,744,77943,610,950 (1) ...
Information mensuelle relative au nombre d'actions et de droits de vote - Février 2026 Information mensuelle relative au nombre d’actions et de droits de voteFévrier 2026 Déclaration faite en application de l'article L. 233-8 II du code de commerce et des articles 221-1 2° f) et 223-16 du règlement général de l’AMF. Le 2 mars 2026 Société déclarante : Nexans S.A.Siège social : 4 Allée de l’Arche – 92400 CourbevoieRCS Nanterre 393 525 852Marché réglementé d’Euronext Paris (Compartiment A) Date Nombre d’actions composant le capital Nombre total de droits de voteThéoriques (1)Exerçables (...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.